Human Genome Epidemiology Literature Finder
|
Records 1 - 17 (of 17 Records) |
| Query Trace: Head and Neck Neoplasms and EGFR[original query] |
|---|
| Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005 Jun 16 (6): 934-41. Etienne-Grimaldi M-C, Pereira S, Magné N, Formento J-L, Francoual M, Fontana X, Demard F, Dassonville O, Poissonnet G, Santini J, Bensadoun R-J, Szepetowski P, Milano |
| Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients. Oral oncology 2007 Aug 43 (7): 713-9. Bandrés Eva, Barricarte Rubén, Cantero Cristina, Honorato Beatriz, Malumbres Raquel, Zárate Ruth, Alcalde Juan, García-Foncillas Jes |
| Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Mar 26 (7): 1119-27. Rudin Charles M, Liu Wanqing, Desai Apurva, Karrison Theodore, Jiang Xuemin, Janisch Linda, Das Soma, Ramirez Jacqueline, Poonkuzhali Balasubramanian, Schuetz Erin, Fackenthal Donna Lee, Chen Peixian, Armstrong Deborah K, Brahmer Julie R, Fleming Gini F, Vokes Everett E, Carducci Michael A, Ratain Mark |
| Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers. Proceedings of the National Academy of Sciences of the United States of America 2011 Nov 108 (47): 19024-9. Morris Luc G T, Taylor Barry S, Bivona Trever G, Gong Yongxing, Eng Stephanie, Brennan Cameron W, Kaufman Andrew, Kastenhuber Edward R, Banuchi Victoria E, Singh Bhuvanesh, Heguy Adriana, Viale Agnes, Mellinghoff Ingo K, Huse Jason, Ganly Ian, Chan Timothy |
| Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study. Journal of oncology 2010 2010 709678. Murray Samuel, Bobos Mattheos, Angouridakis Nikolaos, Nikolaou Angelos, Linardou Helena, Razis Evangelia, Fountzilas Geor |
| Human papillomavirus and gene mutations in head and neck squamous carcinomas. ANZ journal of surgery 2012 May 82 (5): 362-6. Friedland Peter, Thomas Anitha, Naran Anupam, Amanuel Benhur, Grieu-Iacopetta Fabienne, Carrello Amerigo, Harnett Gerald, Meyer Christine, Phillips Micha |
| Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2013 Mar 189 (3): 202-14. Dionysopoulos D, Pavlakis K, Kotoula V, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Nikolaou A, Kalogeras K T, Fountzilas |
| Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response. BMC research notes 2014 7 (1): 337. Boeckx Carolien, Weyn Christine, Vanden Bempt Isabelle, Deschoolmeester Vanessa, Wouters An, Specenier Pol, Van Laer Carl, Van den Weyngaert Danielle, Kockx Mark, Vermorken Jan B, Peeters Marc, Pauwels Patrick, Lardon Filip, Baay Ma |
| PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Jun 21 (11): 2530-7. de la Rochefordiere Anne, Kamal Maud, Floquet Anne, Thomas Laurence, Petrow Peter, Petit Thierry, Pop Marius, Fabbro Michel, Kerr Christine, Joly Florence, Sevin Emmanuel, Maillard Sophie, Curé Hervé, Weber Béatrice, Brunaud Claire, Minsat Mathieu, Gonzague Laurence, Berton-Rigaud Dominique, Aumont Maud, Gladieff Laurence, Peignaux Karine, Bernard Virginie, Leroy Quentin, Bieche Ivan, Margogne Audrey, Nadan AnaTereza, Fourchotte Virginie, Diallo Alhassane, Asselain Benard, Plancher Corine, Armanet Sébastien, Beuzeboc Philippe, Scholl Suzy |
| KIR Genes and Their Ligands Predict the Response to Anti-EGFR Monoclonal Antibodies in Solid Tumors. Frontiers in immunology 2016 7 561. Morales-Estevez Cristina, De la Haba-Rodriguez Juan, Manzanares-Martin Barbara, Porras-Quintela Ignacio, Rodriguez-Ariza Antonio, Moreno-Vega Alberto, Ortiz-Morales Maria J, Gomez-España Maria A, Cano-Osuna Maria T, Lopez-Gonzalez Javier, Chia-Delgado Beatriz, Gonzalez-Fernandez Rafael, Aranda-Aguilar Enriq |
| Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial. Acta oncologica (Stockholm, Sweden) 2018 May 1-6. Brøndum Line, Alsner Jan, Sørensen Brita Singers, Maare Christian, Johansen Jørgen, Primdahl Hanne, Evensen Jan Folkvard, Kristensen Claus Andrup, Andersen Lisbeth Juhler, Overgaard Jens, Eriksen Jesper Gr |
| A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 5 25 (16): 4955-4965. McMichael Elizabeth L, Benner Brooke, Atwal Lakhvir S, Courtney Nicholas B, Mo Xiaokui, Davis Melanie E, Campbell Amanda R, Duggan Megan C, Williams Kallan, Martin Kyle, Levine Kala, Olaverria Salavaggione Gonzalo N, Noel Tiffany, Ganju Akaansha, Uppati Sarvani, Paul Bonnie, Olencki Thomas, Teknos Theodoros N, Savvides Panos, Tridandapani Susheela, Byrd John C, Caligiuri Michael A, Liu Stephen V, Carson William |
| Efficacy of Gefitinib and Methorexate in Patients With Advanced Stage and Recurrent Head and Neck Cancer. Cureus 2021 7 13 (6): e15451. Irshad Razia, Haider Ghulam, Hashmi Madiha, Hassan Anus |
| Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors. Frontiers in oncology 2021 11 752918. Araujo Jhajaira M, Rosas Gina, Belmar-López Carolina, Raez Luis E, Rolfo Christian D, Schwarz Luis J, Infante-Huaytalla Ulises, Paez Kevin J, García Luis R, Alvarado Hober, Ramos Fany P, Delgado-Espinoza Sheyla S, Cardenas-Farfan Jhon B, Cornejo Melanie, Zanabria Daniel, Colonio-Cossio Christian, Rojas-Jefferson Mario, Pinto Joseph |
| EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer. Cancers 2022 5 14 (10): . Cserepes Mihály, Nelh?bel Györgyi A, Meilinger-Dobra Mónika, Herczeg Adrienn, Türk Dóra, Heged?s Zita, Svajda Laura, Rásó Erzsébet, Ladányi Andrea, Csikó Kristóf György, Kenessey István, Szö?r Árpád, Vereb György, Remenár Éva, Tóvári Józs |
| Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8902-8915. Michael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, Sotirios P Fortis, Nikolaos Kesesidis, Christos Kakouratos, Ioannis Karakasiliotis, Constantin N Baxevan |
| The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 05, 2023
- Content source: